All companies › MNPR

MNPR · Monopar Therapeutics

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research case for this company.

Open-market buys0
Open-market sells6
Research cases0
Last filing2026-08-26

Insider flow: Selling only — a count of disclosed transactions, not a rating or a recommendation.

Insider transaction timeline

Every reported transaction, positioned by trade date. Purchases sit above the axis, sales below; circle area is proportional to dollar value. No share-price line is drawn — this feed carries transaction prices only, and a price history inferred from them would imply market data the filings do not contain.

Open-market purchase Open-market sale
2026-08-26 — Tsuchimoto Kim R · sold 485 @ $108.83 2026-08-26 — Tsuchimoto Kim R · sold 615 @ $109.56 2026-08-26 — Tsuchimoto Kim R · sold 700 @ $110.65 2026-08-26 — Tsuchimoto Kim R · sold 1,098 @ $111.84 2026-08-26 — Tsuchimoto Kim R · sold 602 @ $112.93 2026-08-26 — Tsuchimoto Kim R · sold 590 @ $113.84
2026-08-262026-08-26

Insider participation

One row per insider, one cell per reported transaction, shaded by value. Repeat buying and activity clustered in time are visible at a glance.

Tsuchimoto Kim R Director
Included with a free account

The analysis built on top of these filings

The filings above are public record and stay public here. What an account adds for $MNPR is the reading of them — and for this company, that is what the list below says it is, no more.

  • Transaction timelineThe [{'transaction_date': '2026-08-26', 'insider_name': 'Tsuchimoto Kim R', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 485.0, 'price': 108.83, 'value': 52782.55, 'is_buy': False}, {'transaction_date': '2026-08-26', 'insider_name': 'Tsuchimoto Kim R', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 615.0, 'price': 109.56, 'value': 67379.4, 'is_buy': False}, {'transaction_date': '2026-08-26', 'insider_name': 'Tsuchimoto Kim R', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 700.0, 'price': 110.65, 'value': 77455.0, 'is_buy': False}, {'transaction_date': '2026-08-26', 'insider_name': 'Tsuchimoto Kim R', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 1098.0, 'price': 111.84, 'value': 122800.32, 'is_buy': False}, {'transaction_date': '2026-08-26', 'insider_name': 'Tsuchimoto Kim R', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 602.0, 'price': 112.93, 'value': 67983.86, 'is_buy': False}, {'transaction_date': '2026-08-26', 'insider_name': 'Tsuchimoto Kim R', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 590.0, 'price': 113.84, 'value': 67165.6, 'is_buy': False}] reported transactions plotted over the window rather than listed, so concentration is visible.

Not available for MNPR today: no reported open-market purchases in this window, so there is no insider cost basis to compute; no research case — nothing here has cleared the scoring threshold. Both appear on this page on their own if that changes.

A free account opens all of it.

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.